title: Substitution of dalteparin with enoxaparin-a cautionary note.
authors.forename: Conor
authors.initials: C
authors.lastname: Magee
authors.forename: Jonathan
authors.initials: J
authors.lastname: Barry
authors.forename: Shafiq
authors.initials: S
authors.lastname: Javed
authors.forename: Robert
authors.initials: R
authors.lastname: Macadam
authors.forename: David D
authors.initials: DD
authors.lastname: Kerrigan
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D050110:Bariatric Surgery / Q000009:adverse effects*; D017985:Dalteparin / Q000009:adverse effects* / Q000627:therapeutic use; D017984:Enoxaparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009765:Obesity / Q000601:surgery; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D006113:United Kingdom; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D017985:Dalteparin